Core Viewpoint - Hengxin Dongfang has been investigated by the China Securities Regulatory Commission (CSRC) for suspected violations of information disclosure laws [2][3]. Group 1: Investigation Details - On August 12, Hengxin Dongfang announced that it received a notice of investigation from the CSRC due to suspected violations of information disclosure laws, as per the Securities Law of the People's Republic of China [3]. - The company is cooperating with the CSRC during the investigation and is conducting self-examinations of its information disclosure practices [5]. Group 2: Financial Adjustments - Hengxin Dongfang identified accounting errors in its 2022 annual report and has adjusted its revenue recognition method for its computing system integration and technical services business from the gross method to the net method, reducing its 2022 revenue by 182 million yuan, which is 37.12% of the previously reported revenue [6][7]. - After the adjustment, the company's 2022 revenue stands at 308 million yuan [6]. Group 3: Historical Performance - The company has experienced significant financial challenges, with a substantial decline in performance since 2019 and continued losses since 2020 [8]. - As of August 12, the company's stock price was 7.17 yuan per share, with a total market capitalization of 4.3 billion yuan [10].

Core Viewpoint - Hengxin Dongfang has been investigated by the China Securities Regulatory Commission (CSRC) for suspected violations of information disclosure laws, as announced on August 12 [1][3]. Group 1: Investigation and Disclosure - Hengxin Dongfang received a notice from the CSRC regarding the investigation based on the Securities Law and the Administrative Penalty Law of the People's Republic of China [1]. - The company stated that it will actively cooperate with the CSRC during the investigation and will continue to conduct self-examinations of its information disclosure practices [3]. Group 2: Financial Adjustments - The company identified accounting errors in its 2022 annual report and opted for retrospective restatement, adjusting its revenue recognition method from gross to net, which reduced its 2022 revenue by 182 million yuan, representing a 37.12% decrease from the previously reported figure [3][4]. - After adjustments, Hengxin Dongfang's 2022 revenue was reported at 308 million yuan [3]. Group 3: Financial Performance - Hengxin Dongfang has experienced significant financial challenges, with a substantial decline in performance since 2019 and continued losses since 2020 [6]. - As of August 12, the company's stock price was 7.17 yuan per share, with a total market capitalization of 4.3 billion yuan [8].

Group 1 - Funi Dongfang Equipment Technology Co., Ltd. announced that the total amount of external guarantees by the company and its subsidiaries is expected to exceed 100% of the audited net assets attributable to the parent company for the most recent year [1] - The guarantee amount for units with a debt-to-asset ratio exceeding 70% is expected to exceed 50% of the audited net assets attributable to the parent company for the most recent year [1] - The total upper limit of external guarantees for the upcoming year is estimated at RMB 1,185 million [1] Group 2 - The company received a notice from the China Securities Regulatory Commission regarding an investigation into suspected violations of information disclosure laws [1] - The investigation is based on the Securities Law of the People's Republic of China and the Administrative Penalty Law [1]

Core Viewpoint - Hengxin Dongfang (300081.SZ) has received a notice from the China Securities Regulatory Commission (CSRC) regarding an investigation for suspected violations of information disclosure laws [1] Summary by Relevant Sections - Company Announcement - The company announced on August 12, 2025, that it received the "Notice of Investigation" (No. 证监立案字0142025029号) from the CSRC [1] - The investigation is based on allegations of illegal information disclosure [1] - Regulatory Context - The CSRC's decision to initiate the investigation is in accordance with the Securities Law of the People's Republic of China and the Administrative Penalty Law [1]

恒信东方（300081）公告，公司于2025年8月12日收到中国证监会下发的《立案告知书》，因涉嫌信息 披露违法违规，中国证监会决定对公司立案。公司自查发现2022年年报存在会计差错，采用追溯重述法 调整相关事项。目前公司经营活动正常，该事项不会对公司经营产生重大影响。 ...

Core Viewpoint - The article discusses the legal actions taken against Gel Software and other parties involved in the fraudulent issuance and information disclosure violations related to Zeda Yisheng Technology Co., Ltd, highlighting the financial implications and the ongoing litigation process [2][4]. Group 1: Legal Proceedings - On August 12, Gel Software announced that it, along with 38 other defendants, is being sued for a total of approximately 37,227.26 million yuan across three cases related to fraudulent issuance and information disclosure violations [2]. - The three cases involve claims of 12,345.51 million yuan, 21,533.20 million yuan, and 3,348.55 million yuan respectively, with the total amount claimed being 37,227.26 million yuan [2]. - The plaintiffs include Dongxing Securities, Tianjian Accounting Firm, and Beijing Kangda Law Firm, all of which were intermediaries in Zeda Yisheng's initial public offering [4]. Group 2: Background and Financial Impact - In April 2023, Zeda Yisheng was penalized by the China Securities Regulatory Commission for fraudulent issuance and information disclosure violations, leading to investor lawsuits against Zeda Yisheng and its intermediaries [4]. - Following the penalties, Dongxing Securities, Tianjian Accounting, and Kangda Law Firm collectively paid approximately 493 million yuan to investors and the regulatory authority, prompting them to seek recovery of these costs through litigation against other involved parties [4]. - Gel Software's involvement stems from business transactions with Zeda Yisheng in 2018 and 2020, which were later found to lack commercial substance during a self-examination process [4].

9月5日，南京红太阳股份有限公司（000525.SZ，以下简称"ST红太阳"）发布公告称，公司收到中国证 券监督管理委员会（以下简称"中国证监会"）《行政处罚决定书》及《市场禁入决定书》。 此前，ST红太阳于2020年7月6日收到中国证监会《调查通知书》，因公司涉嫌信息披露违法违规，根 据《中华人民共和国证券法》的有关规定，中国证监会决定对ST红太阳进行立案调查。 经查明，红太阳存在以下违法事实：未按规定披露控股股东及其关联方非经营性占用资金的关联交易， ST红太阳及其子公司于2012至2016年间向南一农集团及其关联方提供存货、资金的关联交易，应在 2012至2016年年度报告中披露而未披露，涉及金额合计125,100,498元，累积影响至《2018年年度报告》 《2019年半年度报告》。 同时，在ST红太阳《2019年年度报告》《2020年半年度报告》及《关于控股股东及其关联方归还上市 公司非经营性占用资金的公告》中存在虚假记载，控股股东及其关联方未实质归还占用资金,经红太阳 质押担保，南一农集团及其关联方开具银行承兑汇票合计2,996,523,515.64元，共开银行承兑汇票126 张。 ST红太阳未及 ...

原标题：突发！证监会立案！ 依据中青宝公告，经与张云霞核实，公司梳理相关事项情况如下：2023年12月29日，张云霞因存在 债务纠纷案件，在民事纠纷案件解决过程中因涉嫌拒不执行判决、裁定罪被深圳市公安局福田分局采取 强制措施并收到《取保候审决定书》；2024年7月9日，张云霞收到深圳市福田区人民检察院出具的《不 起诉决定书》和《解除取保候审决定书》，因相关债务纠纷所涉及的仲裁裁决确定内容已经全部履行完 毕，深圳市福田区人民检察院决定对张云霞不起诉并解除对张云霞的取保候审措施。至此，案件程序终 结。 业绩大幅下滑 10月29日晚，中青宝对外公告，因涉嫌信息披露违法违规，公司实际控制人李瑞杰被证监会立案。 根据中青宝2024年半年报，公司实际控制人为李瑞杰和张云霞夫妇。7月26日，中青宝收到深圳证 监局出具的行政监管措施决定书，深圳证监局对公司采取责令改正措施，理由是张云霞因涉嫌犯罪被依 法采取强制措施，公司在知悉张云霞被采取强制措施后未及时披露相关事项。 8月9日，中青宝发布公告称，公司及张云霞因涉嫌信息披露违法违规，中国证监会决定对公司及张 云霞进行立案。 实控人被证监会立案 中青宝10月29日晚间披露关于实 ...

彼时，*ST长方称，经长达两天时间，共挖出377箱（塑料周转箱50厘米×40厘米×30厘米）会计原 始凭证资料等，挖掘掩埋资料的坑长约9米、宽约5米、深约5米，资料所属期间为2013年至2021年，被 掩埋的资料均为用于会计核算的原始凭证单据等。 因内斗事件备受市场关注的*ST长方与其子公司康铭盛，日前受到监管部门处罚。近日，*ST长方 公告，公司收到深圳证监局对康铭盛相关责任人出具的《行政处罚决定书》（下称《决定书》），及深 圳证监局对公司及公司相关责任人出具的《行政处罚事先告知书》（下称《事先告知书》）。 公告显示，因存在拒绝、阻碍监督检查的违法行为，深圳证监局决定对时任康铭盛执行董事李迪初 等三人责令改正，分别处以100万元罚款。同时，因子公司康铭盛虚增利润和应收账款，导致*ST长方 2020年、2021年年报存在虚假记载，深圳证监局拟对*ST长方及多名责任人给予警告，分别处以100万 元至500万元不等的罚款。 曾上演多出内斗闹剧 据悉，康铭盛是*ST长方为完善在LED产业的布局而并购的子公司。由于并购时达成的约定，在并 购完成后的很长一段时间内，康铭盛的实际管理一直由李迪初等康铭盛原管理团队负责。 ...

Core Viewpoint - Tian Sheng Pharmaceutical Group Co., Ltd. is under risk warning due to the alleged misappropriation of company funds by its controlling shareholder, Liu Qun, which has led to the implementation of risk warnings on its stock trading since June 5, 2019 [2][3]. Group 1: Risk Warning Implementation - The stock trading of Tian Sheng Pharmaceutical has been subject to risk warnings since June 5, 2019, due to allegations against controlling shareholder Liu Qun for misappropriating company funds [2][3]. - Liu Qun's assets related to the case have been seized, frozen, or sealed, making it unlikely for the funds to be returned within a month [3]. Group 2: Measures Taken and Progress - The company has enhanced training for its board members and management on relevant laws and regulations to improve compliance awareness and ensure effective implementation of internal controls [4]. - As of April 8, 2021, Liu Qun has fully repaid the misappropriated funds, totaling RMB 125,074,926, including interest [5][8]. - The company has engaged Beijing Xinghua Accounting Firm to audit the repayment situation, which confirmed that all funds have been repaid, although uncertainties remain regarding the completeness and accuracy of the repayment [5][6]. Group 3: Legal Proceedings and Outcomes - On December 29, 2023, the Chongqing First Intermediate People's Court issued a judgment ordering Liu Qun to repay RMB 9,182.4926 million and RMB 3,325 million, both of which have been returned [7]. - Liu Qun appealed the judgment, but on August 8, 2024, the Chongqing High People's Court upheld the original ruling, confirming the total misappropriated amount [8]. - The company is currently under investigation by the China Securities Regulatory Commission (CSRC) for alleged violations of information disclosure laws [9].